Fuse Cobalt Inc
Change company Symbol lookup
Select an option...
FUSEF Fuse Cobalt Inc
FSLY Fastly Inc
BNR Burning Rock Biotech Ltd
FCNKX Fidelity® Contrafund® Fund Class K
CAT Caterpillar Inc
POAGX PRIMECAP Odyssey Aggressive Growth Fund
VFIFX Vanguard Target Retirement 2050 Fund Investor Shares
CMCSA Comcast Corp
CUZ Cousins Properties Inc
ZM Zoom Video Communications Inc
Go

Materials : Metals & Mining | Small Cap Value
Based in Canada
Company profile

Fuse Cobalt Inc., formerly LiCo Energy Metals Inc, is a Canada-based company engaged in the exploration and development of minerals used in the production of lithium-ion batteries. The Company’s projects include Glencore Bucke Property, Teledyne Cobalt Project and Black Rock Desert Exploration Project. The Glencore Bucke Property is located in the Bucke Township and consists of approximately 16.2 hectares and sits the west boundary of Company’s Teledyne Cobalt Project. The Teledyne Cobalt Project is located at Ontario and covers an area of over 554.6 hectares and consists of over 11 claims. The Black Rock Desert Exploration Project is located in the United States, which covers an area of over 3,980 acres/ 1,610 hectares and consists of approximately 199 placer claims.

Closing Price
$0.06
Day's Change
-0.0015 (-2.49%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0635
Day's Low
0.059
Volume
(Light)
Volume:
193,725

10-day average volume:
278,015
193,725

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRNE, CEMI and JCOM

10:53 am ET July 27, 2020 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / July 27, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)Class Period: May 15, 2020 - May 22, 2020Lead Plaintiff Deadline: July 27, 2020

The complaint alleges that throughout the class period Sorrento Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in SRNE: http://www.kleinstocklaw.com/pslra-1/sorrento-therapeutics-inc-loss-submission-form?id=8190&from=1

Chembio Diagnostics, Inc. (NASDAQ:CEMI)Class Period: March 12, 2020 - June 16, 2020Lead Plaintiff Deadline: August 17, 2020

According to the filed complaint, defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Chembio's stock price and operated as a fraud or deceit by misrepresenting the efficacy of the Company's Dual Path Platform ("DPP") COVID-19 test. Defendants allegedly achieved this by making false statements about Chembio's DPP COVID-19 test, although they knew or at least recklessly disregarded that there were material performance concerns with the test. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Chembio stock fell precipitously as the prior artificial inflation came out of Chembio's stock price.

Learn about your recoverable losses in CEMI: http://www.kleinstocklaw.com/pslra-1/chembio-diagnostics-inc-loss-submission-form?id=8190&from=1

J2 Global, Inc. (NASDAQ:JCOM)Class Period: October 5, 2015 - June 29, 2020Lead Plaintiff Deadline: September 8, 2020

The complaint alleges that during the class period J2 Global, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) J2 Global engaged in undisclosed related party transactions; (2) J2 Global used misleading accounting to hide requisite impairments and underperformance in acquisitions; (3) several so-called independent members of the Company' board of directors and audit committee were not disinterested; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Learn about your recoverable losses in JCOM: http://www.kleinstocklaw.com/pslra-1/j2-global-inc-loss-submission-form?id=8190&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118jk@kleinstocklaw.comTelephone: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.com

SOURCE: The Klein Law Firm

View source version on accesswire.com: https://www.accesswire.com/599035/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-SRNE-CEMI-and-JCOM

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.